Science patient regains vision after PRIMA implant
The first blind patient in a Stargardt disease trial saw letters and read words during rehab sessions, proving the therapy's potential for retinal conditions.
See the latest news and media coverage for Science. We track all announcements, press releases, and industry mentions in real time, all in one place.
Clinical-stage medical technology company
science.xyzLast updated
In short: Science launched PRIMA in Europe, reported 36-month data, and raised $230 million.
The first blind patient in a Stargardt disease trial saw letters and read words during rehab sessions, proving the therapy's potential for retinal conditions.
The organization is seeking a candidate for this role and encourages applications or sharing with the network.
The BCI implant shows improved efficacy at month 36 compared to month 6. No new safety signals emerged during the long-term follow-up.
Former Chief Strategy Officer and investor joins the role to leverage his medical device experience and drive commercial growth.
Science Corporation, the neural engineering and brain-computer interface (BCI) company, today announced long-term (36 months) followup data from its pivotal PRIMAvera clinical trial (NCT04676854). The...
Science Corporation, a startup developing novel brain-computer interfaces (BCI), won approval from Europe’s medical device regulator to begin selling a device that restores vision lost...
Science Corporation announced the European commercial launch of its Prima brain-computer interface (BCI) implant for vision restoration.
Science Corporation, the startup from former Neuralink president and co-founder Max Hodak, has enlisted a top neurobiologist to lead the first U.S.
Track Science and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Science and other trending companies.